Turgeon Michael K, Cardona Kenneth
Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, 1365 Clifton Road, NE, Building B, Suite 4100, Office 4201, Atlanta, GA 30322, USA.
Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, 550 Peachtree Street, NE, 9th Floor, Suite 900, Atlanta, GA 30308, USA.
Surg Clin North Am. 2022 Aug;102(4):601-614. doi: 10.1016/j.suc.2022.04.004.
Retroperitoneal sarcomas (RPS) are a rare subset of soft tissue sarcoma that are composed of only a few histologic subtypes, each with a distinct tumor biology, clinical presentation, preferred treatment strategy, recurrence risk, and surveillance plan. In the modern era of precision medicine, our understanding of the implications of subtype tumor biology and anatomic location has led to a more nuanced, histology-specific approach to therapy, including surgery, neoadjuvant radiation therapy, and/or chemotherapy. This article provides a summary of recent updates to the management of RPS.
腹膜后肉瘤（RPS）是软组织肉瘤中罕见的一个亚组，仅由少数组织学亚型组成，每种亚型都有独特的肿瘤生物学特性、临床表现、首选治疗策略、复发风险和监测计划。在精准医学的现代时代，我们对亚型肿瘤生物学和解剖位置影响的理解，已导致采用更细致入微、针对特定组织学的治疗方法，包括手术、新辅助放疗和/或化疗。本文总结了腹膜后肉瘤管理方面的最新进展。
